Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
NCT00359463
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Purpura, Thrombocytopaenic, Idiopathic
Interventions
DRUG:
eltrombopag
Sponsor
GlaxoSmithKline